These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 6179458)

  • 41. Receptors in immunology.
    Gmelig Meyling FH
    Neth J Med; 1985; 28(2):63-8. PubMed ID: 3919325
    [No Abstract]   [Full Text] [Related]  

  • 42. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
    Feger U; Luther C; Poeschel S; Melms A; Tolosa E; Wiendl H
    Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of T-regulatory cells in multiple sclerosis].
    Rojas JI; González SJ; Patrucco L; Cristiano E
    Medicina (B Aires); 2010; 70(1):79-86. PubMed ID: 20228030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mechanism of immune response].
    Gülmezoğlu E
    Mikrobiyol Bul; 1982 Jul; 16(3):217-23. PubMed ID: 6820118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis.
    Link J; Fredrikson S; Söderström M; Olsson T; Höjeberg B; Ljungdahl A; Link H
    Ann Neurol; 1994 Feb; 35(2):197-203. PubMed ID: 7509140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Target antigens in neuroimmunological diseases].
    Tabira T
    Nihon Rinsho; 1994 Nov; 52(11):2855-60. PubMed ID: 7996680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
    Shinomiya N; Yata J
    Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
    Zhang J; Zhou WB; Wang HL; Guo SS
    Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell subset interactions in the regulation of syngeneic tumor immunity.
    Perry LL; Greene MI
    Fed Proc; 1981 Jan; 40(1):39-44. PubMed ID: 6450065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Humoral factors in inflammatory disorders of the central and peripheral nervous system.
    Tindall RS
    J Neuroimmunol; 1988 Dec; 20(2-3):283-96. PubMed ID: 2848863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A 'profile' of immune responsiveness in multiple sclerosis.
    Symington GR; Mackay IR; Whittingham S; White J; Buckley JD
    Clin Exp Immunol; 1978 Feb; 31(2):141-9. PubMed ID: 306322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathomechanisms of autoantibody production against the nervous system].
    Arimura K
    Brain Nerve; 2013 Apr; 65(4):323-32. PubMed ID: 23568980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Myasthenia gravis. Etiopathogenesis].
    Pérez Ramírez JL; Cornejo Barrera M; Pérez Mijares R
    Rev Clin Esp; 1977 Jun; 145(6):401-6. PubMed ID: 302012
    [No Abstract]   [Full Text] [Related]  

  • 55. Possible strategies for the treatment of myasthenia gravis and other autoimmune diseases.
    Nossal GJ
    Ann N Y Acad Sci; 1987; 505():610-8. PubMed ID: 3500669
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunology of auto-immune disorders].
    Berthaux P
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):165-73. PubMed ID: 4543895
    [No Abstract]   [Full Text] [Related]  

  • 57. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular and cellular events in normal and abnormal immune responsiveness.
    Michael JG; Krieger NJ
    Clin Physiol Biochem; 1983; 1(2-5):179-93. PubMed ID: 6084575
    [No Abstract]   [Full Text] [Related]  

  • 59. [Role of thymus epithelial tissue in the formation of natural immune tolerance].
    Beletskaia LV; Gnezditskaia EV
    Usp Sovrem Biol; 1975; 79(1):128-37. PubMed ID: 1092082
    [No Abstract]   [Full Text] [Related]  

  • 60. How to recognize an antibody-mediated autoimmune disease: criteria.
    Drachman DB
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():183-6. PubMed ID: 2183310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.